Find Federal Grants
Substance Abuse and Mental Health Services Adminis · SM-18-017
National Institutes of Health · RFA-RM-18-007
Enhancing Innovations in Emerging Technologies for Advanced Manufacturing of Complex Biologic Products (R01)
Food and Drug Administration · RFA-FD-18-023
Targeted In Vivo Delivery of Gene Therapeutics for HIV Cure (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-18-016
National Institutes of Health · PAR-18-764
FY18 Announcement of the Availability of Funds for Phase I New and Innovative Strategies (Tier 2) to Prevent Teenage Pregnancy and Promote Healthy Adolescence
Office of the Assistant Secretary for Health · AH-TP2-18-001
FY18 Announcement of Availability of Funds for Phase I Replicating Programs (Tier 1) Effective in the Promotion of Healthy Adolescence and the Reduction of Teenage Pregnancy and Associated Risk Behaviors
Office of the Assistant Secretary for Health · AH-TP1-18-001
BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-NS-18-030
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
National Institutes of Health · PAR-18-762
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
National Institutes of Health · PAR-18-763
State Essentials for Childhood Initiative: Implementation of Strategies and Approaches for Child Abuse and Neglect Prevention
Centers for Disease Control - NCIPC · CDC-RFA-CE18-1803
Limited Competition: Interaction of HIV Infection and Alcohol Abuse on Central Nervous System Morbidity (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AA-18-011
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
National Institutes of Health · PAR-18-761
FY 18 Announcement of Availability of Funds for a Clinical Training and Technical Assistance Project to Support the Title X Family Planning Program
Office of the Assistant Secretary for Health · PA-FPT-18-001
Assistant Secretary for Preparedness and Response · EP-IDS-18-001
Summer Institute for Research Education in Biostatistics (R25 - Clinical Trials Not Allowed)
National Institutes of Health · RFA-HL-19-019
In Vivo Synaptic Function in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed)
National Institutes of Health · PAR-18-760
Family-to-Family Health Information Centers – Delaware, Hawaii, Maine, Montana, Nevada
Health Resources and Services Administration · HRSA-18-113
Novel Nucleic Acid Sequencing Technology Development (R43/R44 Clinical Trial Not Allowed)
National Institutes of Health · RFA-HG-18-003
Novel Nucleic Acid Sequencing Technology Development (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-HG-18-001